Union Chimique Belge logo

Union Chimique Belge

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

UCB is a biopharma company that focuses on the research and development of medication for neurology and immunology diseases.

Investor Profile

Union Chimique Belge has made 11 investments, with 0 in the past 12 months and 27% as lead.

Stage Focus

  • Series C (18%)
  • Seed (18%)
  • Series B (18%)
  • Corporate Round (18%)
  • Series A (18%)
  • Series Unknown (9%)

Country Focus

  • United States (64%)
  • Canada (9%)
  • Switzerland (9%)
  • Spain (9%)
  • Belgium (9%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Biopharma
  • Health Diagnostics
  • Medical Device
  • Information Technology
  • Therapeutics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Union Chimique Belge frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Sabby Capital
North America, New Jersey, United States, Upper Saddle River
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
BDC Healthcare Venture
North America, Quebec, Canada, Montréal
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Apple Tree Partners
North America, New York, United States, New York
Co-Investments: 1
Janus Capital Group
North America, Colorado, United States, Denver
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Union Chimique Belge?

Neurava

West Lafayette, Indiana, United States

Neurava has developed wearable diagnostics for epilepsy patients including those at risk of SUDEP.

Health CareHealth DiagnosticsMedical Device
SeedApr 3, 2024
Amount Raised: $2,260,000
IMIDomics

Barcelona, Catalonia, Spain

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

BiotechnologyHealth Care
Corporate RoundMar 4, 2024
Bingli

Antwerp, Antwerpen, Belgium

Bingli is a telemedicine consulting service provider company focuses on dynamic patient history and patient planning.

AppsConsultingHealth CareInternetMedicalTelehealth
Series AOct 4, 2022
Amount Raised: $5,391,250
Nile AI

Sherman Oaks, California, United States

Nile AI specializes in the fields of neurology, health-tech, data science, engineering, and communication.

Artificial Intelligence (AI)Health CareHome Health CareSoftware
Corporate RoundJan 13, 2021
Amount Raised: $30,405,044
EYSZ

Piedmont, California, United States

A digital health platform that uses analysis of eye-movements as a biomarker to assess brain health across neurological disorders.

Health CareInformation TechnologyMachine LearningSoftware
SeedJul 1, 2020
Amount Raised: $1,950,000
Aetion

New York, New York, United States

Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

AnalyticsHealth CareSoftware
Series BFeb 5, 2019
Amount Raised: $27,000,000
Ceribell

Mountain View, California, United States

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series BSep 25, 2018
Amount Raised: $35,000,000
StrideBio

Durham, North Carolina, United States

StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.

BiotechnologyHealth CareInformation TechnologyTherapeutics
Series AJun 13, 2018
Amount Raised: $15,700,000
Clementia Pharmaceuticals

Montréal, Quebec, Canada

Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.

BiopharmaBiotechnologyMedical
Series UnknownJun 23, 2015
Amount Raised: $60,000,000
Dermira

Menlo Park, California, United States

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

BiopharmaBiotechnologyPharmaceutical
Series CAug 19, 2014
Amount Raised: $51,000,000